title: Therapeutic applications of CRISPR RNA-guided genome editing.
abstract: The rapid development of programmable nuclease-based genome editing technologies has enabled targeted gene disruption and correction both in vitro and in vivo This revolution opens up the possibility of precise genome editing at target genomic sites to modulate gene function in animals and plants. Among several programmable nucleases, the type II clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated nuclease 9 (Cas9) system has progressed remarkably in recent years, leading to its widespread use in research, medicine and biotechnology. In particular, CRISPR-Cas9 shows highly efficient gene editing activity for therapeutic purposes in systems ranging from patient stem cells to animal models. However, the development of therapeutic approaches and delivery methods remains a great challenge for biomedical applications. Herein, we review therapeutic applications that use the CRISPR-Cas9 system and discuss the possibilities and challenges ahead.
authors: Taeyoung
authors: T
authors: Koo
authors: Jin-Soo
authors: JS
authors: Kim
mesh_terms: D064112:Clustered Regularly Interspaced Short Palindromic Repeats; D000072669:Gene Editing; D015316:Genetic Therapy; D006801:Humans
keywords: CRISPR-Cas9; antibacterial therapy; antiviral therapy; gene correction; gene therapy